Ladenburg Thalmann Financial Services’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-300
Closed -$7K 5512
2019
Q1
$7K Hold
300
﹤0.01% 4561
2018
Q4
$4K Hold
300
﹤0.01% 4716
2018
Q3
$3K Buy
+300
New +$3K ﹤0.01% 4825